James F. List

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

Clifford J. Bailey, Jorge Luiz Gross, Anne Pieters et al. · The Lancet · 2010 · 848 citations

Metabolic Syndrome, Diabetes Management, Inadequate Glycaemic Control +6

Dapagliflozin a glucose‐regulating drug with diuretic properties in subjects with type 2 diabetes

Hiddo J.L. Heerspink, Dick de Zeeuw, Li Wie et al. · Diabetes Obesity and Metabolism · 2013 · 801 citations · Full text

Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise

Ele Ferrannini, Silvia Ramos, Afshin Salsali et al. · Diabetes Care · 2010 · 700 citations · Full text

Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes

James F. List, Vincent Woo, Enrique Morales et al. · Diabetes Care · 2008 · 689 citations · Full text

Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control

Donald E. Kohan, Paola Fioretto, Weihua Tang et al. · Kidney International · 2013 · 633 citations · Full text

Obesity, Metabolic Syndrome, Hypertension +14